DFJ Mercury, a Texas seed-stage venture capital firm investing in information technology and science-based start ups, expanded its investment team with the promotion of Russ Lebovitz, PhD, to Venture Partner, and the hiring of Dan Janiak, PhD, as Associate.
Lebovitz and Janiak will work closely with DFJ Mercury co-founder and Managing Director, Dan Watkins, PhD, in developing and originating science-based investment themes and startup opportunities.
Russ Lebovitz is currently the CEO of Marval Biosciences, Inc. and the founder and Chairman of Imagnx, Inc., both DFJ Mercury portfolio companies. Previously, he was the President and CEO of C-sixty and the subsequent CEO of Tego Biosciences.
Before joining DFJ, Dan Janiak was an Associate in the Physical and Biological Technologies practice at In-Q-Tel, where he served as the lead technical staff member on a number of technology development programs.